Texas Biomedical Research Institute

Texas Biomedical Research Institute (Texas Biomed), located in San Antonio, Texas, is an independent biomedical research institution, specializing in genetics and in virology and immunology. Texas Biomed is funded by government and corporate grants and contracts, and donations from the public. Founded in 1941 by Tom Slick as the Foundation of Applied Research, Texas Biomed became the Southwest Foundation for Research and Education in 1952, Southwest Foundation for Biomedical Research (SFBR) in 1982, and Texas Biomedical Research Institute on February 1, 2011. Located on a 200-acre (0.81 km) campus on the northwest side of San Antonio, Texas Biomed employs over 75 doctoral level biomedical scientists, including 28 principal investigators and 400 staff members. Focused on basic biomedical research, the Institute is divided into the Department of Genetics and the Department of Virology & Immunology. The Southwest National Primate Research Center, a part of Texas Biomed, is an international resource that provides specialized facilities and expertise in research with nonhuman primates to investigators from around the US and other countries. It maintains 4,000 nonhuman primates.


Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed


Researchers pinpoint most likely source of HIV rebound infection

In findings that have implications for potential new HIV therapies, researchers from Texas Biomedical Research Institute (Texas Biomed) used genetic sequencing techniques on the nonhuman primate version of the virus to identify ...

Medical research

Scientists discover new method Ebola virus uses to infect cells

Understanding how viruses travel once inside the human body is critical to develop effective drugs and therapies that can stop viruses in their tracks. Scientists at Texas Biomedical Research Institute (Texas Biomed) recently ...

Diseases, Conditions, Syndromes

Cancer therapy shows promise against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

Diseases, Conditions, Syndromes

Prior dengue infection may make Zika virus outcomes worse

Researchers in New York and Texas have identified that female marmosets are more likely to transmit the Zika virus during pregnancy if they have been previously infected by a different virus, dengue. The findings, published ...

Diseases, Conditions, Syndromes

Therapy shows promise to help clear tuberculosis

Texas Biomedical Research Institute scientists have identified a promising way to help fight tuberculosis (TB), a disease that still kills nearly 2 million people annually. The research focuses on a potential host-directed ...

Oncology & Cancer

Modified bladder cancer treatment shows promise in animal studies

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show ...

Medical research

Institute working to accelerate COVID-19 drug development

As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...

page 1 from 6